The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19823573.
- Also identified by DOI 10.1371/journal.pmed.1000161 and PMC identifier 2753665.
- Licence recorded as CC0.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Chand Khanna and colleagues describe the work of the Comparative Oncology Trials Consortium (COTC), which provides infrastructure and resources to integrate naturally occurring dog cancer models into the development of new human cancer drugs, devices, and imaging techniques.
Medical subject headings
- Clinical Trials as Topic
- Dog Diseases
- Drug Screening Assays, Antitumor
- Models, Animal
- Multicenter Studies as Topic
- National Cancer Institute (U.S.)
- Neoplasms